For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Cygnus Therapeutic Systems

USPTO Granted Patents = 23

Forward Citations = 1,236

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Gary W Cleary (10 out of 16 patents)

Chia-Ming Chiang (7 out of 22 patents)

Kenneth J Colley (4 out of 4 patents)

4. Paul R Stauffer (3 out of 11 patents)

5. Gordon L Flynn (3 out of 9 patents)

6. Kuldeepak Sharma (3 out of 4 patents)

7. Donald R Wilson (3 out of 4 patents)

8. Richard H Guy (3 out of 14 patents)

9. Hirohisa Okuyama (3 out of 4 patents)

10. Durairaj Bommannan (3 out of 4 patents)

11. Renee A Fallon (3 out of 4 patents)

12. Ooi Wong (2 out of 6 patents)

13. Jesus Miranda (2 out of 10 patents)

14. Samir D Roy (2 out of 2 patents)

15. Darth M Dunbar (2 out of 3 patents)

23 patents: Sort by Forward Citations

1. 5378473 - Transdermal administration of short or intermediate half-life (1995-01-03),

2. 5358715 - Enhancement of transdermal drug delivery using monoalkyl phosphates and (1994-10-25),

3. 5352456 - Device for administering drug transdermally which provides an initial (1994-10-04),

4. 5323769 - Ultrasound-enhanced delivery of materials into and through the skin (1994-06-28),

5. 5308625 - Enhancement of transdermal drug delivery using monoalkyl phosphates and (1994-05-03),

6. 5273756 - Transdermal drug delivery device using a membrane-protected microporous (1993-12-28),

7. 5273755 - Transdermal drug delivery device using a polymer-filled microporous (1993-12-28),

8. 5271940 - Transdermal delivery device having delayed onset (1993-12-21),

9. 5252335 - Transdermal administration of lisuride (1993-10-12),

10. 5252334 - Solid matrix system for transdermal drug delivery (1993-10-12),

11. 5246706 - Device for administering bimakalim transdermally (1993-09-21),

12. 5234690 - Transdermal drug delivery device using an unfilled microporous membrane (1993-08-10),

13. 5231975 - Ultrasound-enhanced delivery of materials into and through the skin (1993-08-03),

14. 5229129 - Transdermal administration of lisuride (1993-07-20),

15. 5225198 - Transdermal administration of short or intermediate half-life (1993-07-06),

Company Overview

Cygnus Therapeutic Systems is a biotechnology company based in Redwood City, California, specializing in the development of innovative drug delivery systems. The organization focuses on creating advanced transdermal delivery technologies that enhance the therapeutic efficacy of medications while improving patient compliance. By leveraging its expertise in formulation science and device engineering, Cygnus aims to address unmet medical needs across various therapeutic areas, contributing to the evolution of patient-centric healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

23 Patents

#86 in Redwood City, CA

#3,421 in California

#14,438 in US

#27,714 in the World

Redwood City, CA, United States of America

Cygnus Therapeutic Systems

Forward Citations = 1,236

23 inventors:

Gary W Cleary (10 out of 16 patents)

Chia-Ming Chiang (7 out of 22 patents)

Kenneth J Colley (4 out of 4 patents)

4. Paul R Stauffer (3 out of 11 patents)

5. Gordon L Flynn (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cygnus Therapeutic Systems. Retrieved from https://idiyas.com/company/cygnus-therapeutic-systems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…